Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with ...
Jun 21, 2011
1
1
Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today.
Jun 27, 2019
0
0
Linagliptin (trade name: Trajenta) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled ...
Jan 6, 2012
0
0
Four tobacco companies filed a lawsuit against the US Food and Drug Administration (FDA) on Tuesday over what they say are unconstitutional requirements for warning labels on US cigarette packaging.
Aug 17, 2011
73
0
The six-minute walking distance test (6MWD), a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive ...
May 16, 2011
0
0
When a headache calls and the only ibuprofen in the house is a bottle that is expired, is it worth a trip out to replace it?
Oct 24, 2023
0
3
(AP) -- The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications like Excedrin and Gas-X made at a Novartis manufacturing ...
Jan 9, 2012
1
0
U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought.
Apr 1, 2020
0
129
The U.S. Food and Drug Administration has sent a warning letter to one of America's biggest bakeries, asking the company to stop claiming there are allergens such as sesame or nuts in products when in fact they are not there.
Jun 28, 2024
0
31
Abiraterone (trade name: Zytiga) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic ...
Jan 6, 2012
0
0
